Research Tools

OptoCeutics

Brief Description

Advancing non-invasive light technologies to stimulate the brain and improve cognitive function.

Through clinical trials, Optoceutics tests and develop solutions to treat and diagnose neurodegenerative diseases using emerging gamma stimulation therapy and digital biomarkers.

40 Hz light for gamma stimulation has been shown to improve memory and cognitive performance in a mouse model of Alzheimer's disease. 40 Hz light stimulation reduced amyloid plaque associated with Alzheimer's disease in the brain of mice by about 50%. Optoceutics develops a masked 40 Hz...

IntegenX

Brief Description

IntegenX is the market leader of Rapid DNA technology for human identification in forensics and law enforcement applications. IntegenX’s RapidHIT technologies integrate advanced fluidics, optics, and biochemistry capabilities to produce sample-to-answer solutions for DNA-based human identity testing. The RapidHIT ID System for Crime Labs generates lab-...

Apertor Pharmaceuticals

Brief Description

Apertor creates novel molecular glues for therapeutic applications in multiple disease areas. The company applies a world-class synthetic biology platform using non-model organisms, a deep knowledge of complex natural products relevant to human health, and a computational pipeline enabled by structure-guided design. The result is a first-in-class approach to solving important pharmacological problems and delivering new, high-value treatment options for patients. The company was co-founded by UC Berkeley Professor of Chemical & Biomolecular Engineering and of...

BioAmp Diagnostics

Brief Description

BioAmp develops novel, instrument-free screening and diagnostic tools to identify antibiotic-resistant bacteria in patient samples.

Timeline 2017. Company founded, and participated in the Citris Foundry accelerator program Inventors

Tara DeBoer, Niren Murthy, Jessica Marie Palomino, Lee Woodland Riley

Cell-X

Brief Description

Editing T-cells with nanopore-electroporation to improve CRISPR-Cas9 editing capabilities.

Timeline 2021. Company founded Inventors

YuHong Cao, Jennifer Doudna, Enbo Ma, Peidong Yang

Epigenetic Gene Editing

Brief Description

Epigenetic Gene Editing is a gene editing tools company dedicated to improvements in CRISPR-Cas9 editing by providing a fusion protein kit to gene editing companies.

Formerly known as EPI-CRISPRx.

Timeline 2021. Company founded Inventors

Enrique Lin Shiao, Jennifer Doudna

IMYu

Brief Description

Rejuvenation therapy based on a modified version of an already FDA-approved plasma exchange technique known as plasmapheresis, in which a machine separates the plasma (the liquid part of the blood) from the blood cells and then returns the blood to the person receiving treatment. The company's approach, called next gen-apheresis, promises to spur the rejuvenation of organs and tissues as people age.

Timeline 2019. Company founded Inventors

Irina Conboy, Michael Conboy, Wendy Cousin, Christian Elabd, Yutong Liu, Melod Mehdipour, David...

EZNome, Inc.

Brief Description

EZNome commercializes high-throughput mammalian genome editing technologies utilizing CRISPR ribonucleoprotein (RNP) electroporation of zygotes (CRISPR-EZ).

Timeline 2018. Company founded. Inventors

Sean Chen, Lin He, Yiu-Fai Lee

Dahlia Biosciences

Brief Description Dahlia Biosciences is leading the development of cell-based RNA detection tools using CRISPR technology. The foundational RNA-targeting Cas9 technology was invented by Dr. Mitchell O’Connell and Dr. Sam Sternberg in the laboratory of Dr. Jennifer Doudna at UC Berkeley.

The company's vision is to empower scientists to study and isolate cells at high resolution via sensitive, robust, and multiplexed RNA detection in both fixed and live cells.

Timeline 2011. Company founded Inventors

Jennifer Doudna, Mitchell O'Connell, Benjamin Oakes,...

Namuh

Brief Description Namuh is on a mission to close the nutritional gap between infant formula and human milk. The company provides parents with infant nutrition closest to breast milk at the molecular level, using only clean and thoughtfully-sourced human milk ingredients so parents can nourish their babies with confidence. This is made possible by NAMUH’s proprietary yeast-based technology to create human milk oligosaccharides (HMOs), the critical missing ingredient, structurally identical to those found in breast milk. Powered by the clean HMOs and partnerships with premium protein/lipid...